CAR T-Cell Therapy Induces Response in NHL and CLL
An anti-CD19 chimeric antigen receptor (CAR) T-cell-transduced natural killer (NK) therapy induced responses in patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL),...
Roxadustat Safe and Effective: Analyses of Pooled Results
Analyses of pooled results of phase 3 studies of roxadustat for the treatment of anemia in patients with chronic kidney disease (CKD)
HIMALAYAS Study: Roxadustat versus Epoetin Alfa
The HIMALYAYAS trial was a phase 3 study of the efficacy and safety of roxadustat in the treatment of anemia in incident dialysis patients.
9/11 First Responders at Higher Risk for Developing These Cancers
A study published in JNCI Cancer Spectrum observed an increased risk of prostate cancer, thyroid cancer, and leukemia in 9/11 first responders.
The study included...
Children Conceived with Fertility Treatment at Slight Increased Risk for Cancer
A new study observed that children born after a frozen embryo transfer had a “small but statistically significant increased risk” of developing childhood cancer.
“Children...
Patients with Acute Leukemia Treated with Anthracyclines Have Increased Risk for Heart Failure
Patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) who are treated with anthracyclines have an elevated risk of heart failure, according...
Roxadustat Safe and Effective in Pooled Results
Analyses of pooled results of phase 3 studies of roxadustat for the treatment of anemia in patients with chronic kidney disease (CKD), including dialysis-dependent...
